跳至主要内容
临床试验/CTRI/2024/04/066434
CTRI/2024/04/066434已完成2 期

Efficacy of Homoeopathic Antimiasmatic Medicines in Recurrent Urinary Tract Infections in Menopausal Womens A Prospective study

DR BHAVANA CHAUDHARY1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年5月7日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
1 Significant Improvement No Recurrencey Total control of the symptoms

研究概览

简要总结

This study is a Prospective Study pre test-post test one group Experimental study to assess the efficacy of Homoeopathic Antimiasmatic Medicine for 8 months in 40 participants with Recurrent UTI in Menopausal Womens that will be conducted as per inclusion and exclusion criteria from outpatient department and the outcomes measures will assess the reduction in frequency and urinary symptoms of the participants follow up as per need of case at every 7 or 15 days up to for 8th months of duration

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
45.00 Year(s) 至 55.00 Year(s)(—)
性别
Female

入选标准

  • 1 Cases with history of urinary tract infections 2-3 episodes within the 6 month will be selected irrespective of socio Economic conditions 2 Samples are selected only by symptomatic verification of Recurrent UTIs according to ICD 10 Criteria Code Z87 440.

排除标准

  • 1 Patients suffering from other severe Renal diseases such as Severe Pyelonephritis Nephritis syndrome Chronic Renal failure Renal Stone 2 Patients under any other alternative treatment and Homoeopathic treatment 3 Patients suffering from other Complicated Systemic Disease such as Diabetes mellitus Hypertension Hyperthyroidism.

结局指标

主要结局

1 Significant Improvement No Recurrencey Total control of the symptoms

时间窗: At baseline and after the treatment that is at the end of 8 month duration

2 Improvement Recurrencey Once in 6 month Symptomatic relief

时间窗: At baseline and after the treatment that is at the end of 8 month duration

3 Status quo Recurrencey No any Improvements in signs and symptoms

时间窗: At baseline and after the treatment that is at the end of 8 month duration

4 Left the Treatment Worsening of Complaints

时间窗: At baseline and after the treatment that is at the end of 8 month duration

次要结局

  • Not Applicable(Not Applicable)

研究者

发起方
DR BHAVANA CHAUDHARY
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Bhavana Chaudhary

Smt A J Savla Homoeopathic Medical College and Research Institute Mehsana Gujarat

研究点 (1)

Loading locations...

相似试验